Compare up to 4 stocks side by side, across all 7 of StockIQ's scoring categories.
| Category | KURA Kura Oncology, Inc. | AAPG Ascentage Pharma Group International - American Depository |
|---|---|---|
| Price | $11.30 -2.2% | $16.00 -2.5% |
| StockIQ Score | 45D+ Moderate Risk: Medium | 35F Weak Risk: High |
| Technical | 39F | 13F |
| Fundamental | 39F | 35F |
| Growth | 40D | 50C- |
| Fair Value | 38F | 38F |
| News | 92A+ | 50C- |
| Quality | 47D+ | 50C- |
| Risk | 46D+ | 40D |
Scores are based on real financial data only and do not constitute investment advice. How the score is calculated
KURA leads in investor (45 vs 35), technical (39 vs 13) and fundamental scores (39 vs 35), while AAPG has the higher growth score (50 vs 40). Both have the same valuation score of 38. Overall, KURA’s rating is MODERATE compared with AAPG’s WEAK.
